Cargando…
Fbxw7-associated drug resistance is reversed by induction of terminal differentiation in murine intestinal organoid culture
Colorectal cancer (CRC) is one of the top three cancer-related causes of death worldwide. FBXW7 is a known tumor-suppressor gene, commonly mutated in CRC and in a variety of other epithelial tumors. Low expression of FBXW7 is also associated with poor prognosis. Loss of FBXW7 sensitizes cancer cells...
Autores principales: | Lorenzi, Federica, Babaei-Jadidi, Roya, Sheard, Jonathan, Spencer-Dene, Bradley, Nateri, Abdolrahman S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830362/ https://www.ncbi.nlm.nih.gov/pubmed/27110583 http://dx.doi.org/10.1038/mtm.2016.24 |
Ejemplares similares
-
FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation
por: Babaei-Jadidi, Roya, et al.
Publicado: (2011) -
FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15
por: Li, Ningning, et al.
Publicado: (2015) -
An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance
por: Li, Ningning, et al.
Publicado: (2019) -
FLYWCH1, a Multi-Functional Zinc Finger Protein Contributes to the DNA Repair Pathway
por: Almozyan, Sheema, et al.
Publicado: (2021) -
Anti-miR-135/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids
por: Babaei-Jadidi, Roya, et al.
Publicado: (2022)